NeuroPace Inc. 8-K Filing: Key Updates and Insights - January 2025
Here are the extracted key pieces of information from the provided section of the financial report:
- Entity Information:
- Company Name: NeuroPace Inc.
- SEC CIK Number: 0001528287
- Address: 455 N. Bernardo Avenue, Mountain View, CA 94043
- Contact Number: (650) 237-2700
- Filing Details:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: January 6, 2025
- Period Covered: January 6, 2025 (indicating a specific event or update on that date)
- Stock Information:
- Common Stock: Par value of $0.001 per share
- Ticker Symbol: NPCE
- Exchange: NASDAQ
- Company Identifier:
- IRS Employer Identification Number (EIN): 22-3550230
- SEC Central Index Key (CIK): 0001528287
Insights:
- The filing is an 8-K, indicating that NeuroPace Inc. has reported a significant event that requires disclosure. The specific nature of the event would need to be examined in the full 8-K document.
- The company operates in the biotechnology or medical technology sector, suggested by the name NeuroPace, which may indicate a focus on neurological treatments.
- As a publicly traded company on NASDAQ, it is subject to regular reporting requirements with the SEC, indicating transparency and regulatory compliance.
- The date of the filing may be significant for investors looking to understand any recent developments or changes within the company.
This information can be useful for investors, analysts, and stakeholders who are monitoring developments related to NeuroPace Inc.